By binding to this unique residue, EN4 reduces stability of Myc and its obligate partner, Max, thus reducing the DNA binding ability of the Myc-Max complex and its capability to carry out proliferation and tumorigenesis activity in cancer cells. Here, MYC is linked to cancer.